CareRx Publishes Q3 2026 Earnings Presentation

PUBT · 3d ago
CareRx Publishes Q3 2026 Earnings Presentation
  • CareRx’s revenue rose to $95.3 million for the third quarter ended September 30, 2026, from $93.2 million a year earlier.
  • Adjusted EBITDA totaled $8.1 million, with an adjusted EBITDA margin of 8.5%; ward bed changes and higher labor costs weighed on profitability.
  • Net income fell to $200,000 from $1.6 million, mainly reflecting deferred tax asset utilization and refinancing transaction costs.
  • Average beds serviced reached 93,225; onboarding a new national customer added approximately 3,000 beds.
  • Cash from operations declined to $6.5 million from $10.1 million a year earlier.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CareRx Corporation published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.